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The paper will describe practical ways in which these skills 
might be of use to clinicians in a radiotherapy setting.  
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Due to advances in medical treatments such as surgery, 
radiotherapy, chemotherapy and hormonal therapy; it is 
expected that 68% of adults diagnosed with cancer today will 
be alive in 5 years time (Li et al 2014). 
This growth in the number of survivors who are living longer 
after cancer has generated increased attention to follow up 
care. Follow up care encompasses prevention, detection and 
treatment as well as the long term physical and psychological 
effects of cancer and its’ treatment (Forsythe et al 2014).  
The importance of assessing psychological distress at key 
points after a cancer diagnosis has been highlighted by 
several cancer networks. Distress can appear on a continuum 
ranging from common feelings of vulnerability and sadness to 
fears which may become disabling and lead to anxiety, 
depression or panic (Smith et al 2013). 
In the context of survivorship supports which aid an individual 
cope with their diagnosis of cancer and improve their quality 
of life become paramount. Support groups are an integral 
part of the support network and have been found to be very 
beneficial to both people directly affected by cancer and 
those close to them (Gottlieb & Wachala 2007). 
The average annual incidence of brain tumours in Ireland 
between 2008-2010 was 344. This was reported by the 
National Cancer Registry. This presentation will explore the 
Irish experience of a support group for people diagnosed with 
a brain tumour and the role of the RTT within it. It offers the 
RTT a different perspective on the people we treat everyday 
and how we can be of help to them. 
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In 1994, Eddie Naessens had a superficial parotidectomy to 
remove Adenoid Cystic Carcinoma. He was twenty-four at the 
time. A substantial recurrence was not diagnosed until 2001. 
Faced with a poor prognosis and conflicting advice he sought 
second opinions from cancer centres in the US and Europe. In 
2002, he underwent radical surgery followed by adjuvant RT 
at another Dublin hospital. 
His presentation connects his personal experience to work in 
social psychology. He discusses the psychological and social 
impact of diagnosis and treatment, his experience and 
insights dealing with an array of medical practitioner styles, 
and his fears and psychological approach to coping. He 
identifies what helped, what hindered and why it should 
matter to health professionals. Drawing on work in 
psychological research he frames his patient experience in a 
way that provides insights for both patients and 
practitioners. 
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Purpose/Objective: It is essential to engage patients in 
treatment decision making process. Slowly medical care is 
moving from emphasizing only 'survival' to 'quality' of 
existence of the individual. This study was done to assess the 
patient's perception about benefits of concurrent 
chemoradiation (CTRT) and various common side effects in 
treatment of Head Neck cancer. 
Materials and Methods: A prospective evaluation of decision 
making process for CTRT in head and neck cancers was done – 
pre CTRT, immediately after CTRT and 3 months after CTRT. 
The interviews consisted of a semi-structured questionnaire 
with free text options in some questions. There were 
questions on patient's views on Ryle's tube insertion, febrile 
neutropenia, nausea/vomiting and acceptance of morphine. 
They were also asked about their treatment preference on a 
hypothetical graded scale of survival benefit. Prior to the 
interview patients were updated about possible side effects 
of CTRT such they were are able to give a balanced view on 
their choices.  
Results: 30 patients with locally advanced head and neck 
cancer planned for CTRT were included in the study. Median 
age was 57 years (IQR 46 – 57.2 years) and 5 out 30 were 
women. Pre CTRT 80% (24/30) patients accepted to be 
treated by a Ryle's Tube as compared to 47% after 3 months 
of CTRT (x2 2.7, p<0.1). Pre CTRT 6/30 preferred not to be on 
a Ryle's at all based on 'past experience with Ryle's tube', 
'stigma of being seen with a Ryle's tube' and 'fear of pain'. 
Prior to CTRT, 83% (25/30) patients as compared to only 50% 
patient after 3 months of CTRT valued a 5% absolute survival 
benefit of CTRT. On 3 months post CTRT follow-up 53% 
patients felt that 6 weeks of CTRT was very painful period for 
them and one third of patients regretted taking CTRT. No 
significant fear observed among the patients for febrile 
neutropenic sepsis, nausea/vomiting. Acceptance for 
morphine was quite well throughout the therapy and most of 
them believe morphine is necessary for better pain control.  
Conclusions: Patient's preferences change over time and 
initially patients are more accepting of side effects and 
treatments with marginal benefits. Following CTRT almost 
50% patients do not value a 5% survival benefit and many 
regretted their decision to have CTRT. It's important that 
doctors are aware about patient's changing perceptions about 
the same treatment and discuss pros and cons of treatment 
in this context.  
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Purpose/Objective: The aim of this study is to evaluate 
knowledge and perception of radiation oncology (RO) by the 
Belgian general population. An online study in 2011 by 
Yougov in the UK, based on 2297 responses, observed a 
